As of July 1, 2026, eligible Medicare Part D beneficiaries can access three FDA-approved GLP-1 medications for chronic weight management at a flat $50 per month medication copay
This science-backed method revolves around activating key arousal pathways with an FDA-approved peptide: PT-141 (bremelanotide), commonly known as the "Pink Shot." It addresses hypoactive sexual desire disorder (HSDD) by stimulating brain receptors involved in sexual motivation, leading to increased desire, better lubrication, heightened sensitivity, reduced pain during intercourse, and greater overall satisfactionwithout directly altering hormones.[1][2][3] Clinical trials show it can significantly improve sexual function scores in premenopausal women with HSDD, with up to 51% reporting enhanced desire compared to placebo groups, but its benefits extend to perimenopausal and postmenopausal women dealing with vaginal atrophy and low libido.[1] Weve long known that peptides can influence sexual health, but PT-141 stands out as the first FDA-approved injectable specifically for HSDD in women
The biologically active enantiomer LC mediates the transport of long-chain fatty acids into the mitochondrial matrix for cellular energy metabolism and has antioxidant and anti-inflammatory properties (Abdulidha et al
Treatment Blood blisters are not typically harmful, and they will often heal without treatment
In male infertility caused by obesity and diabetes due to poor lifestyle, appropriate exercise may improve intra-testicular spermatogenesis and semen quality by increasing testicular antioxidant defense, improving apoptosis, reducing pro-inflammatory cytokine levels, and enhancing the steroid-producing process (Minas et al
Animal studies have provided evidence for the role of vitamin D in autoimmune thyroid diseases
.png)
